tiprankstipranks
Advertisement
Advertisement

QNCX Stock Latest News

QNCX Earnings this Week: How Will it Perform?
Pre-EarningsQNCX Earnings this Week: How Will it Perform?
5d ago
QNCX
Quince Therapeutics management to meet with Oppenheimer
PremiumThe Fly
Quince Therapeutics management to meet with Oppenheimer
11d ago
QNCX
Quince Therapeutics Announces Leadership Transition to Orphai Team
PremiumCompany Announcements
Quince Therapeutics Announces Leadership Transition to Orphai Team
14d ago
8K
QNCX
Quince Therapeutics registers to sell 15.47M shares of common stock for holders
PremiumThe Fly
Quince Therapeutics registers to sell 15.47M shares of common stock for holders
14d ago
QNCX
Reddit initiated, Caterpillar downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Reddit initiated, Caterpillar downgraded: Wall Street’s top analyst calls
16d ago
F
BE
Quince Therapeutics initiated with an Outperform at Oppenheimer
PremiumThe FlyQuince Therapeutics initiated with an Outperform at Oppenheimer
16d ago
QNCX
Biohaven, Quince, Iridium, EasyJet, Logitech Trending by Analysts
Premium
Weekend Updates
Biohaven, Quince, Iridium, EasyJet, Logitech Trending by Analysts
1M ago
BHVN
IRDM
Quince Therapeutics trading halted, news pending
Premium
The Fly
Quince Therapeutics trading halted, news pending
2M ago
QNCX
Analyst Reiterates Buy on Quince Therapeutics, Citing Differentiated LAM-001 Mechanism, Underserved PH-ILD Market, and Solid Cash Runway
PremiumRatings
Analyst Reiterates Buy on Quince Therapeutics, Citing Differentiated LAM-001 Mechanism, Underserved PH-ILD Market, and Solid Cash Runway
2M ago
QNCX
Upcoming Stock Splits This Week (June 29 to July 3) – Stay Invested
PremiumMarket News
Upcoming Stock Splits This Week (June 29 to July 3) – Stay Invested
2M ago
GDC
HON
Take-Two, Quince, Tonix, CoreWeave, Affirm Trending With Analysts
PremiumWeekend Updates
Take-Two, Quince, Tonix, CoreWeave, Affirm Trending With Analysts
2M ago
AFRM
CRWV
Quince Therapeutics Implements 1-for-20 Reverse Stock Split
PremiumCompany Announcements
Quince Therapeutics Implements 1-for-20 Reverse Stock Split
2M ago
8K
QNCX
Quince Therapeutics initiated with an Outperform at Leerink
PremiumThe FlyQuince Therapeutics initiated with an Outperform at Leerink
2M ago
QNCX
Quince Therapeutics initiated with an Overweight at Cantor Fitzgerald
Premium
The Fly
Quince Therapeutics initiated with an Overweight at Cantor Fitzgerald
2M ago
QNCX
Quince Therapeutics initiated with an Overweight at Cantor Fitzgerald
Premium
The Fly
Quince Therapeutics initiated with an Overweight at Cantor Fitzgerald
2M ago
QNCX
Quince Therapeutics Stockholders Approve Reverse Split Authorization
PremiumCompany Announcements
Quince Therapeutics Stockholders Approve Reverse Split Authorization
2M ago
8K
QNCX
Quince Therapeutics Regains Nasdaq Compliance, Avoids Delisting Risk
PremiumCompany Announcements
Quince Therapeutics Regains Nasdaq Compliance, Avoids Delisting Risk
3M ago
8K
QNCX
Quince Therapeutics Closes Orphai Deal and Secures Funding
PremiumCompany Announcements
Quince Therapeutics Closes Orphai Deal and Secures Funding
3M ago
8K
QNCX
Quince Therapeutics announces LAM-001 data
PremiumThe Fly
Quince Therapeutics announces LAM-001 data
3M ago
QNCX
Quince Therapeutics acquires Orphai Therapeutics, terms undisclosed
PremiumThe FlyQuince Therapeutics acquires Orphai Therapeutics, terms undisclosed
3M ago
QNCX
Is QNCX a Buy, Before Earnings?
Premium
Pre-Earnings
Is QNCX a Buy, Before Earnings?
3M ago
QNCX
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
3M ago
BAC
IRE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >